Ozempic and similar drugs are popular with consumers for their weight-loss properties, but a new study suggests they could ...

A new review reports that nine people taking semaglutide and tirzepatide — the active ingredient in GLP-1 medications — ...

A small percentage have had vision problems, but a direct causal link with the drugs has not been established.

Novo Nordisk announced plans for a longer phase III trial testing its investigational obesity drug CagriSema, with regulatory ...

The company states the acquisition will further MERIT’s service offerings, allowing for a seamless transition from ...

The risk of systemic side effects is greater in infants than in adults due to increased percutaneous drug absorption and lower blood volume. The closed eyes technique of eyedrop administration is ...

A new study adds to a growing body of research suggesting a potential link between popular GLP-1 medications like Ozempic and vision loss.

Preservatives are added to multidose medication bottles to inhibit microbial contamination. An assortment of different preservative formulations has been used in ophthalmic medicines and many of ...

A new study suggests that a common type of blood pressure medication, known as Calcium Channel Blockers (CCBs), might ...

Regeneron Pharmaceuticals Inc.’s stock rose 4.9% Tuesday to put it on track for its biggest one-day gain in almost two years, ...

State leaders are reviving talk of importing prescription drugs from Canada, even as US drugmakers and health-care attorneys ...

A new study suggests popular weight-loss drugs like Ozempic and Zepbound may be linked to rare eye conditions that could ...